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Abstract (249words) 27 
Objective Patellofemoral joint osteoarthritis (PFJ OA) contributes considerably to knee OA 28 
symptoms. This study aimed to determine the efficacy of a PFJ-targeted exercise, education manual-29 
therapy and taping program compared to OA education alone, in participants with PFJ OA. 30 
Methods: A randomised, participant-blinded and assessor-blinded clinical trial was conducted in 31 
primary-care physiotherapy. 92 people aged ≥40 years with symptomatic and radiographic PFJ OA 32 
participated. Physiotherapists delivered the PFJ-targeted exercise, education, manual-therapy and 33 
taping program, or the OA-education (control condition) in 8 sessions over 12 weeks.  34 
Primary outcomes at 3-month (primary) and 9-month follow-up: (i) patient-perceived global rating of 35 
change (ii) pain visual analogue scale (100mm); and (iii) activities of daily living (ADL) subscale of the 36 
Knee injury and Osteoarthritis Outcome Score.  37 
Results: 81 people (88%) completed the 3-month follow-up and data analysed on an intention-to-38 
treat basis. Between-group baseline similarity for participant characteristics was observed. The 39 
exercise, education, manual-therapy and taping program resulted in more people reporting much 40 
improvement (20/44) than the OA-education group (5/48) (number needed to treat 3 (95% 41 
confidence interval (CI) 2 to 5)) and greater pain reduction (mean difference: -15.2mm, 95%CI -27.0 42 
to -3.4). No significant effects on ADL were observed (5.8; 95%CI -0.6 to 12.1). At 9 months there 43 
were no significant effects for self-report of improvement, pain (-10.5mm, 95%CI -22.7 to 1.8) or ADL 44 
(3.0, 95%CI -3.7 to 9.7). 45 
Conclusion: Exercise, education, manual-therapy and taping can be recommended to improve short-46 
term patient rating of change and pain severity. However over 9-months, both options were 47 
equivalent. 48 
 49 
Trial Registration: Australian New Zealand Clinical Trials Registry (ACTRN12608000288325): 50 
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=82878’ 51 
 52 
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Introduction 54 
Patellofemoral joint osteoarthritis (PFJ OA) remains an under-recognized category of arthritis. 55 
Evident in almost 70% of adults with knee pain
[1-5]
, it is more prevalent than tibiofemoral (TFJ) OA
[1-3, 56 
5, 6]
. Patellofemoral OA is observed early in the trajectory of knee OA disease process
[7]
, and is 57 
observed in 55% of people aged under 50 years
[3]
. Since the PFJ contributes more to the symptoms 58 
of knee OA than the TFJ 
[4, 8, 9]
, PFJ OA can adversely affect quality of life, economic productivity and 59 
daily function in younger adults with critical career and childcare responsibilities.  60 
 61 
Clinical guidelines prioritise conservative (non-pharmacological) treatments as a first line knee OA 62 
management and recommend tailoring treatments to the location of joint damage
[10-12]
 (i.e., to the 63 
PFJ compartment for individuals with PFJ OA). Many trials have evaluated physical therapies for 64 
patients with predominantly TFJ OA
[13]
. It is notably that PFJ OA severity limited the effectiveness of 65 
exercise and manual-therapy applied to those with predominant TFJ OA
[14, 15]
, supporting the 66 
recommendation for targeted interventions. Only two clinical trials specifically assessed treatments 67 
for PFJ OA, with no positive effects reported for either combined exercise therapy with patellar 68 
taping
[16]
 or patellofemoral bracing
[17]
. The lack of benefit may reflect the lack of tailoring of exercise 69 
and patellar taping to the individual
[16, 17]
 or the use of a single treatment component (bracing)
[17]
.  70 
 71 
The Consensus Statement from the 3rd International Patellofemoral Research Retreat
[18]
 suggested a 72 
disease continuum that manifests as PFJ pain in younger adults and PFJ OA at later stages 
[19, 20]
. 73 
Common impairments include patellar malalignment
[21-23]
, quadriceps and hip muscle weakness
[24-29]
. 74 
This provides a rationale to consider treatments designed for PFJ pain in younger adults for older 75 
people with PFJ OA. Our previous clinical trials proved the effectiveness of quadriceps and hip 76 
muscle retraining exercises, patellar taping, and patellar mobilisation for PFJ pain in younger 77 
adults
[30, 31]
. 78 
 79 
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We aimed to evaluate whether a PFJ-targeted program that combined (i) exercise, (ii) education, (iii) 80 
manual therapy and (iv) taping, results in greater improvements in patient rated change, pain and 81 
physical function than physiotherapist-delivered OA education in participants with symptomatic and 82 
radiographic PFJ OA. We hypothesised that the PFJ-targeted program of exercise, education, 83 
manual-therapy and taping would be superior to the OA-education at 3 months, and that beneficial 84 
effects would not be present at 9-months.  85 
 86 
Methods 87 
Design Overview 88 
We conducted a randomised, assessor- and participant-blinded controlled clinical trial, as described 89 
previously
[32]
. The trial was prospectively registered in the Australian New Zealand Clinical Trials 90 
Registry (ACTRN12608000288325). The study had ethical approval (HREC number: 0721163) and all 91 
participants provided written informed consent prior to commencement, and all human testing 92 
procedures undertaken conformed to the standards of the Declaration of Helsinki.  93 
 94 
Setting and Participants 95 
The clinical trial was conducted in primary care physiotherapy practices. Volunteers from the greater 96 
Melbourne (Australia) area responded to advertisements in print and radio media, posters in 97 
sporting clubs, health and medical practices and referrals from practitioners. Potential participants 98 
underwent telephone screening, followed by a physical screening by an experienced physiotherapist 99 
and standardised weight-bearing semi-flexed, standing, posteroanterior and skyline radiographs to 100 
assess the severity of TFJ and PFJ OA.  101 
 102 
To be included, volunteers were required to be aged at least 40 years; have anterior or retro-patellar 103 
pain that was aggravated by two or more PFJ-loaded activities (e.g. stair ambulation, rising from 104 
sitting or squatting); have an average pain score of at least 3 on an 11-point scale (0=no pain; 105 
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10=worst pain possible) during aggravating activities and on most days during the past month; and 106 
have evidence of lateral PFJ osteophytes
[33]
 on weight-bearing skyline radiographs
[34]
. Participants 107 
were excluded if they had pain from other lower-limb sites; predominantly TFJ joint symptoms on 108 
clinical examination (e.g. location of pain, tenderness on palpation); current or previous (prior 12 109 
months) physiotherapy for knee pain; recent knee injections (prior 3 months); previous or planned 110 
(following 6 months) knee surgery; physical inability to undertake testing; other medical conditions; 111 
inability to understand written and spoken English; and a body mass index (BMI) greater than 34 112 
kg.m
-2
. Additionally, individuals with medial > lateral PFJ osteophytes or moderate-to-severe 113 
concomitant TFJ OA (Kellgren and Lawrence
[35]
 grade >2) were excluded. 114 
 115 
Randomisation and Interventions 116 
The randomisation sequence (computer-generated permuted blocks of 8 to 12) was generated a 117 
priori and kept external (University of Queensland) to the administration site (University of 118 
Melbourne) by an independent investigator. Participants were randomly allocated to either exercise, 119 
education, manual-therapy and taping or OA-education and were informed that two types of 120 
physiotherapist-delivered treatments were being compared, but the types of intervention and study 121 
hypotheses were concealed. A research assistant, not involved in outcome assessment, revealed the 122 
allocation to the physiotherapist delivering the intervention following baseline assessment and prior 123 
to the first appointment. 124 
 125 
Each participant attended the private practice of one of eight trained project physiotherapists, at 126 
various Melbourne metropolitan sites. Physiotherapists were experienced in treating patients with 127 
knee and PFJ conditions and underwent 6 hours of training (with KMC) to standardise the treatment 128 
elements and their prescription, as described in the published protocol
[32]
. Physiotherapists provided 129 
both the active and control interventions and thus were not blinded to group allocation. Eight 130 
treatments (approximately 60 minutes duration) were provided once a week for 4 weeks and then 131 
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once every two weeks for 8 weeks for each group. The interventions have been described in detail 132 
previously
[32]
.  133 
 134 
The PFJ-targeted exercise, education, manual-therapy and taping program was standardised to 135 
consist of (i) functional retraining exercises for the quadriceps and hip muscles; (ii) quadriceps and 136 
hip muscle strengthening; (iii) patellar taping; (iv) manual-therapy (PFJ, TFJ and soft tissue 137 
mobilisation); and (v) OA-education (Supplementary Table). The standard elements of the treatment 138 
were then tailored, such that each participant’s clinical presentation (e.g. strength, pain severity, 139 
swelling) as well as the presence of co-morbidities (e.g. back and hip pain or pathology) were taken 140 
into consideration, and exercises were chosen and progressed by the physiotherapist based on each 141 
participant’s response to exercise load. This approach ensured that the highest level of load could be 142 
applied, whilst keeping the participant’s pain to a minimal level (≤2 on a 0-11 numerical rating scale). 143 
Exercises were taught and supervised by the physiotherapist during each visit with a home exercise 144 
program prescribed, to be performed independently at home 4 times per week. An exercise manual 145 
was provided for participants with clear instructions and diagrams to ensure correct and safe 146 
performance of all exercises. At the completion of the 3-month intervention period and outcome 147 
assessment, participants were encouraged to continue with their home exercise program.  148 
 149 
The OA-education intervention (control group) was a physiotherapist-delivered series of single-150 
patient sessions, designed to control for the patient-therapist interaction and psychosocial contact 151 
inherent with the PFJ-specific physiotherapy intervention. The information was obtained from the 152 
Arthritis Victoria patient information sheets (http://www.arthritisvic.org.au), and at each session 153 
different topics were discussed (1: introduction to OA; 2: maintaining physical activity; 3: medicines; 154 
4: complementary therapies; 5: healthy eating; 6 dealing with chronic pain; 7: emotions and 155 
depression and 8: summary, revision of key concepts).  156 
 157 
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Participants in both groups were encouraged to continue regular physical activity that did not 158 
provoke their pain. The use of adjunctive treatments (including prescription and over-the-counter 159 
medicines) were permitted and recorded in weekly log books.  160 
 161 
Outcome measurements 162 
A blinded examiner administered all outcome measures. In those with bilateral symptoms, the most 163 
symptomatic eligible knee was assessed. Participant characteristics were recorded at baseline. The 164 
principal time-point for efficacy analyses was at treatment completion (3 months), with a secondary 165 
follow-up time-point included after 6 months of no treatment to assess maintenance of effects (9 166 
months). 167 
 168 
Primary outcomes were patient-perceived global rating of change (from baseline) on a 5 point Likert 169 
scale (5=much worse; 4=worse; 3=same; 2=improved; 1=much improved)
[30]
, knee pain severity 170 
during an aggravating activity on a 0-100mm visual analogue scale (VAS)
[32]
 and the activities of daily 171 
living (ADL) subscale of the Knee injury and Osteoarthritis Outcome Score (KOOS)
[36]
. The KOOS-ADL 172 
subscale is identical to the physical function subscale of the Western Ontario and McMasters 173 
Universities Osteoarthritis Index (WOMAC)
[37]
, and a normalised score was calculated (100 174 
represents no symptoms and 0 represents maximum symptoms). Secondary outcome measures 175 
included the pain, symptoms, sport and recreation and quality-of-life subscales of the KOOS. 176 
Adherence was measured from attendance at physiotherapy and completion of home exercise log 177 
books. Adverse events and medication use were recorded in log books. Participants were considered 178 
to be adherent with the home exercises if they completed 3 of the required 4 times per week (i.e. 179 
75%). 180 
 181 
Sample size 182 
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Based on our previous RCT of PFJ-targeted physiotherapy for PFJ pain 
[31]
, we required 38 people per 183 
group to detect 49% of people in the physiotherapy group reporting much improvement on the 184 
global rating of change, compared with 19% of people in the education group, with 80% power 185 
(α=0.05). A sample size of 90 also enabled detection of the minimal clinically important 186 
improvements of 19.9 (21.5) mm on a 100mm pain VAS and 9.1 (13.9) normalised units on the 187 
WOMAC physical function subscale 
[38]
, with 90% power (α=0.05) and accounting for approximately 188 
10% dropouts. 189 
 190 
Statistical analysis 191 
All analyses were performed with SPSS for Windows 21.0 software (SPSS, Chicago, IL, USA), 192 
conducted on an intention-to-treat basis. Global rating of change was dichotomised as no success 193 
(much worse, worse, same, moderate improvement) and success (marked improved), and expressed 194 
as relative risk reduction and Numbers Needed to Treat (NNT). Worst-case scenario imputation of 195 
missing values was performed, with targeted physiotherapy assigned much worse and OA-education 196 
assigned much improved. We analysed continuous outcome measures using linear mixed regression 197 
models, including their respective baseline scores as a covariate, participants as a random effect, 198 
treatment condition as a fixed factor and the covariate by treatment interaction. Analyses were 199 
repeated with participant characteristics (age, gender, BMI and radiographic disease severity) 200 
included as covariates to evaluate their impact. Regression diagnostics were used to check for 201 
normality of the measures and homogeneity of variance, where appropriate. Statistical significance 202 
was set at p = 0.05.  203 
 204 
Results 205 
Between August 2008 and December 2010, 365 people volunteered to participate in the study. In 206 
total, 92 people (Figure 1) fulfilled the eligibility criteria and were randomised to the PFJ OA-targeted 207 
exercise, education, manual-therapy and taping protocol (n=44) and OA-education control (n=48) 208 
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groups; 81 people completed the 3-month follow-up (39 physiotherapy and 42 OA-education; 88%) 209 
and 73 people completed the 9-month follow-up (35 physiotherapy and 38 OA-education; 79%). The 210 
two groups were similar at baseline for all participant characteristics (Table 1). The characteristics of 211 
the 11 participants lost to follow-up were not different to those who completed the study.  212 
 213 
Primary outcomes 214 
The exercise, education, manual-therapy and taping resulted in more people being much improved 215 
(20/44) than the OA-education group (5/48) at 3-months (relative risk 4.31; 95% confidence interval 216 
(CI): 1.79 to 10.36; NNT 3 (95% CI: 2 to 5) (Figure 2). The worse-case scenario imputation of missing 217 
values, with the exercise, education, manual-therapy and taping intervention assigned much worse 218 
and the OA-education assigned much improved, did not change the outcome substantially or 219 
statistically beyond 0.05. People in the combined exercise, education, manual-therapy and taping 220 
group reported significantly greater reductions in pain than those in the OA-education group (mean 221 
difference: -15.2 mm, 95% CI: -27.0 to -3.4). However, there were no significant effects on physical 222 
function as measured using the KOOS-ADL (5.8; -0.6 to 12.1). Including age, gender, BMI and 223 
radiographic disease severity as covariates did not affect the outcomes and hence, the unadjusted 224 
data are presented (Table 2).  225 
 226 
Secondary timepoint (9 months) 227 
At 9-months, more people in the exercise, education, manual-therapy and taping group than in the 228 
OA-education group reported being much improved (relative risk 3.26 (95% CI 1.46 to 7.26); NNT 3 229 
(95%CI 2 to 7)) (Fig 2). However, imputing missing data (21%) on a worse-case scenario, the results 230 
were no longer statistically significant. No significant between-group differences were observed for 231 
participant-reported knee pain (10.5 mm; 95% CI -1.8 to 22.7), KOOS-ADL (3.0; 95% CI -3.7 to 9.7).  232 
 233 
Secondary outcomes 234 
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At 3-months, the exercise, education, manual-therapy and taping intervention and the OA-education 235 
control resulted in similar outcomes for all secondary outcome measures (Table 3) except for KOOS-236 
pain, where those in the exercise, education, manual-therapy and taping group reported significantly 237 
greater reductions in KOOS-pain than those in the OA-education group (6.0; 95% CI 0.1 to 12.6). 238 
After 6-months of no treatment, there were no significant between-group differences (Table 3). 239 
 240 
Adherence, adverse events, and co-interventions 241 
No significant differences were observed between groups for attendance (mean (SD) number of 242 
sessions: Physiotherapy: 8 (2); OA-education 8 (1)). Log-books for exercise adherence were obtained 243 
from 31 (71%) of the participants in the physiotherapy group. Adherence with home exercises was 244 
recorded by 24 (77%) participants. Adverse events were noted in seven of the participants receiving 245 
the exercise, education, manual-therapy and taping intervention (skin reaction to tape wearing (n = 246 
2)); swelling after treatment (n = 2); and pain in other areas after exercises (back n=1; ankle n= 1; 247 
other knee n=1). All adverse events were mild, did not require medical treatment, nor cause 248 
cessation of treatment (some adjustments to taping and/or exercises were made by the treating 249 
physiotherapist). Use of co-interventions, including medications, was similar between groups. In the 250 
group undertaking exercise, education, manual-therapy and taping, medication use was recorded in 251 
10 people: analgesics (n= 7), non-steroidal anti-inflammatory drugs (n= 4) and glucosamine (n=2). 252 
Similar medication use was recorded in the OA-education group: analgesics (n= 7), non-steroidal 253 
anti-inflammatory drugs (n= 4), glucosamine (n=2) and fish oil (n=1). 254 
 255 
 256 
Discussion 257 
Exercises, education, manual-therapy and taping, targeted to the PFJ resulted in superior outcomes 258 
for patient-perceived change in condition and pain, compared to physiotherapist-delivered OA-259 
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education. However physical function was not different between groups. There were no differences 260 
at 9-months.  261 
 262 
Our study fills a gap in the literature, where most evidence exists for medial TFJ OA. The importance 263 
of our targeted intervention is underpinned by recent recommendations to tailor non-264 
pharmacological management for knee OA 
[10]
. Considering that approximately 70% of people aged 265 
above 50 with knee pain with or without radiographic OA have PFJ involvement, and the differences 266 
between the PFJ and TFJ compartment in joint biomechanics
[39]
, risk factors for disease progression 267 
[40, 41]
 and symptomatic presentations
[27, 29, 42]
, a PFJ OA-focussed intervention is appropriate. 268 
Furthermore, people with PFJ OA derive lesser benefits than those with TFJ OA from a non-specific 269 
exercise therapy
[14]
 that does not consider the unique functional and biomechanical impairments 270 
associated with PFJ OA. Our study shows that three patients with PFJ OA would need to be treated 271 
with our targeted physiotherapy intervention compared to OA-education, for one person to report a 272 
marked improvement in their condition.  273 
 274 
Implications for management of PFJ osteoarthritis 275 
Current management of PFJ OA remains problematic for most health and medical practitioners due 276 
to the lack of trials evaluating treatments tailored to this condition. Our treatment protocol 277 
addressed shortfalls of previous trials. We included information and education that addressed 278 
pacing of activity and discussion of weight management. Most importantly, the exercise program 279 
addressed the impairments commonly observed in PFJ OA (quadriceps and hip muscle weakness), 280 
tailoring the prescription and progression of exercises to individual abilities and co-morbidities. 281 
Patellar malalignment, a prominent feature of PFJ OA
[21-23]
, was assessed for each individual and 282 
addressed with patient-specific mobilisations and taping. 283 
 284 
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The lack of benefit following an additional 6 months of no treatment might indicate that 285 
interventions involving exercise, education, manual-therapy and taping for this patient population 286 
need to be extended. The targeted physiotherapy group was instructed to maintain their home 287 
exercise programme. However, the programme was not supervised or progressed over the following 288 
6 months. Furthermore, adherence to the unsupervised programme is unknown. Considering that 289 
OA is a chronic disease, our results indicate the need for trials with either an extended supervised 290 
treatment duration, or additional means to ensure adherence to an unsupervised programme. 291 
 292 
This study has a number of important strengths. To facilitate recruitment of those with predominant 293 
PFJ OA, our eligibility criteria included history, examination and radiographic criteria. The studied 294 
treatment was evidence-based and incorporated recommendations from clinical guidelines. Our 295 
comparison group (physiotherapist-delivered OA-education) controlled for the patient-therapist 296 
interaction inherent within our targeted physiotherapy intervention and sought to reduce 297 
performance bias. Participants and assessors were blinded to treatment allocation, to reduce the 298 
treatment bias and/or response bias. Adherence to the interventions was high and adverse events 299 
were mild. 300 
 301 
There are some limitations to our study, with the main one being a loss of 21% of participants to 302 
follow up at 9-months. The worse-case scenario imputation for missing data implemented in the 303 
analysis lead to a conclusion of no benefit of exercise, education, manual-therapy and taping over 304 
OA education alone. The impact on the interpretation of the long-term outcomes might undermine 305 
the potentially real benefits of the exercise, education, manual-therapy and taping, because analysis 306 
without worse case scenario imputation showed a beneficial effect of the education, exercise, 307 
manual-therapy and taping program. While there was a 12% loss of participants to follow up on the 308 
primary outcome at 3 months, the effect of the exercise, education, manual-therapy and taping 309 
program was still present on imputing missing data on a worst-case scenario basis. As with other 310 
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non-pharmacological trials, it is not possible to blind the physiotherapists providing the treatment. 311 
Furthermore, the results of this trial cannot be extrapolated to those with different clinical features 312 
or patterns of radiographic OA, and the long-term effects cannot be assumed and should be 313 
evaluated.  314 
 315 
In conclusion, after 3-months an 8-session multi-modal treatment of exercise, OA education, 316 
manual-therapy and taping that was targeted to the PFJ and tailored to individual patients resulted 317 
in superior outcomes for patient-perceived change and pain compared to OA-education alone in 318 
people with predominant PFJ OA. However, there was no significant difference in physical function 319 
and the positive effects observed after 3 months of treatment were not maintained after 6 months 320 
of no treatment. Conservative management of PFJ OA may be enhanced by targeting interventions 321 
to the PFJ compartment. 322 
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Figure 1: CONSORT 2010 Flow Diagram (modified for individual randomized, controlled 
trials of non-pharmacologic treatment)  
Participants lost to follow-up at 3 months were not followed up at 9 months 
 
 
Figure 2: Percentage of participants reporting perceived improvement across categories 
from ‘much improved’ to ‘much worse’. 
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Table 1: Baseline characteristics of participants for Physiotherapy and OA-education 
groups. Values are mean (SD) unless stated otherwise  
 Physiotherapy (n=44)  OA-education (n= 48) 
Age (years) 56 (10) 53 (10) 
Height (m) 1.69 (0.08) 1.70 (0.10) 
Mass (kg) 78 (14) 81 (16) 
BMI (m.kg-2) 27.2 (4.0) 27.9 (4.6) 
Female gender n (%) 24 (45 29 (55) 
KL grade n(%)    
-Grade 0 23 (52)  26 (54) 
-Grade 1 11 (25)  9 (18) 
-Grade 2 10(23) 13 (27) 
PFJ O/P severity n(%)    
-Grade 1 31 (70)  30 (63) 
-Grade 2 8 (18)  12 (25) 
-Grade 3 5 (12)  5 (10) 
BMI body mass index 
€: Physiotherapy n=42; Control n=45 
KL Kellgren and Lawrence grading scale 
[35]
 for the tibiofemoral joint measured from an 
anteroposterior radiograph)  
PFJ O/P severity: Severity of lateral patellar osteophyte measure from a skyline x-ray 
[33]
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Table 2: Mean (SD) scores for continuous primary and secondary outcomes at baseline, 3months and 9 months (adjusted for baseline 
scores), according to group 
 
 Baseline  3 months 9 months 
 
Physiotherapy 
(n=44)  
OA-education 
(n= 48)  
Physiotherapy 
(n=39)  
OA-education  
(n= 42) 
Physiotherapy 
(n=35) 
OA-education  
(n= 34) 
Primary Outcomes        
Knee pain on aggravating activity (0-
100) 
58 (26) 
 
58 (27)  29 (28) 45 (31) 33 (30) 44 (29) 
KOOS-ADL (100-0) 72.2 (14.9)  70.8 (16.9)  83.8 (12.8) 76.6 (14.6)‡ 82.1 (14.8) 77.7 (16.0) 
Secondary Outcomes        
KOOS-Pain (100-0) 64.0 (14.7)  63.4 (14.3)  76.3 (13.4) 69.4 (14.2) ‡ 75.5 (16.5) 73.5 (14.4) 
KOOS-Symptoms (100-0) 64.5 (14.7)  61.2 (17.5)  74.9 (13.7) 68.7 (17.8) ‡ 74.3 (12.6) 71.6 (18.0) 
KOOS-SR (100-0) 42.4 (20.4)  43.4 (21.5)  56.4 (23.3) 48.7 (22.2) ‡ 58.5 (20.7) 53.3 (25.0) 
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KOOS-QoL (100-0) 44.3 (14.2)  39.5 (15.5)  54.7 (20.0) 49.8 (13.8) ‡ 56 (19.6) 52 (15.2) 
Knee pain on aggravating activities measured with a visual analogue scale (mm: 100 = maximal pain possible) 
KOOS-ADL = Activities of daily Living subscale of the Knee injury and Osteoarthritis Outcome Score (100 = best possible score) 
KOOS-Pain = Pain subscale of the Knee injury and Osteoarthritis Outcome Score (100 = best possible score) 
KOOS-Symptoms = Symptoms subscale of the Knee injury and Osteoarthritis Outcome Score (100 = best possible score) 
KOOS-SR = Sport and recreation subscale of the Knee injury and Osteoarthritis Outcome Score (100 = best possible score) 
KOOS-QoL = Quality of Life subscale of the Knee injury and Osteoarthritis Outcome Score (100 = best possible score) 
‡ n=41 
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Table 3: Estimated between-group differences, adjusted for the baseline value of the measure (mean difference and 95% confidence 
intervals), in the change scores from baseline to 3 months and from baseline to 9 months   
 Baseline – 3 months  Baseline – 9 months 
   
Primary Outcomes    
Knee pain on aggravating activity (0-
100) 
-15.2 (-27.0 to -3.4)*  -10.5 (-22.7 to 1.8) 
KOOS-ADL (100-0) 5.5 (-0.6 to 11.2)  3.0 ( -3.7 to 9.7) 
Secondary Outcomes    
KOOS-Pain (100-0) 6.0 (0.1 to 12.6)*  1.4 (-5.2 to 8.0) 
KOOS-Symptoms (100-0) 3.0 (-3.1 to 8.9)  -0.6 (-6.9 to 5.8) 
KOOS-SR (100-0) 8.7 (-1.2 to 18.6)  6.2 (-4.2 to 16.5) 
KOOS-QoL (100-0) -0.1 (-7.1 to 7.0)  -0.9 (-8.3 to 6.5) 
Knee pain on aggravating activities measured with a visual analogue scale (mm: 100 = maximal pain possible) 
KOOS-ADL = Activities of daily Living subscale of the Knee injury and Osteoarthritis Outcome Score (100 = best possible score) 
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KOOS-Pain = Pain subscale of the Knee injury and Osteoarthritis Outcome Score (100 = best possible score) 
KOOS-Symptoms = Symptoms subscale of the Knee injury and Osteoarthritis Outcome Score (100 = best possible score) 
KOOS-SR = Sport and recreation subscale of the Knee injury and Osteoarthritis Outcome Score (100 = best possible score) 
KOOS-QoL = Quality of Life subscale of the Knee injury and Osteoarthritis Outcome Score (100 = best possible score) 
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Excluded  (n=138) 
• Not meeting inclusion criteria (n= 89) 
- Insufficient pain (n=17) 
- Aged < 40 years (n=6) 
- Pain from other structure (n=21) 
- Current/previous physiotherapy (n=3) 
- Planned/previous lower limb surgery (n=6) 
- Body mass index ≥35kg.m
-2
(n=19) 
- Other health problems (n=17) 
• Declined to participate (n= 49 ) 
A
ll
o
ca
ti
o
n
 -
 
p
a
ti
e
n
ts
 
Randomized (n=92) 
E
n
ro
ll
m
e
n
t 
Attended for physical and radiographic screening (n= 227) 
Excluded  (n=135) 
• Not meeting clinical inclusion criteria (n= 10) 
• Not meeting radiographic criteria (n= 121) 
- Medial PFJOA (n=27 
- Kellgren and Lawrence grade ≥3 (n=53) 
- No radiographic OA (n=41) 
• Declined to participate (n= 4) 
Allocated to targeted physiotherapy (n=44) 
• Received allocated intervention (n=40) 
• Did not receive allocated (n=4) 
-could not attend all physiotherapy sessions 
 Physiotherapists (n=8) 
• One physiotherapist per centre 
• Number of participants treated by each 
therapist (median 6; IQR 4-8) 
Assessed for eligibility via telephone (n= 365) 
 Physiotherapists (n=8) 
• One physiotherapist per centre 
• Number of participants treated by each 
therapist (median 5; IQR 4-10) 
Lost to follow-up (n=6) 
- Mother ill (n=1) 
- Could not attend appointment (n=2) 
- Lost contact (n=3) 
Analysed  (n= 42 ) 
A
ll
o
ca
ti
o
n
 -
 
p
h
y
si
o
th
e
ra
p
is
ts
 
3
 m
o
n
th
 
a
ss
e
ss
m
e
n
t 
Allocated to OA-education (n=48) 
• Received allocated intervention (n= 46) 
• Did not receive allocated intervention  (n=2) 
-could not attend all health-education sessions 
Lost to follow-up (n=5) 
- Moved interstate/overseas (n=1) 
- Lost contact (n=2) 
- Unwilling to commit/attend appointment 
Lost to follow-up (n=8) 
- Not interested (n=5) 
- Lost contact (n=3) 
9
 m
o
n
th
 
a
ss
e
ss
m
e
n
t 
Lost to follow-up (n=4) 
- Lost contact (n=2) 
- Not interested (n=2) 
Analysed  (n= 35 ) Analysed  (n= 34 ) 
Analysed  (n= 39 ) 
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Abstract
Background: The patellofemoral joint (PFJ) is one compartment of the knee that is frequently
affected by osteoarthritis (OA) and is a potent source of OA symptoms. However, there is a dearth
of evidence for compartment-specific treatments for PFJ OA. Therefore, this project aims to
evaluate whether a physiotherapy treatment, targeted to the PFJ, results in greater improvements
in pain and physical function than a physiotherapy education intervention in people with
symptomatic and radiographic PFJ OA.
Methods: 90 people with PFJ OA (PFJ-specific history, signs and symptoms and radiographic
evidence of PFJ OA) will be recruited from the community and randomly allocated into one of two
treatments. A randomised controlled trial adhering to CONSORT guidelines will evaluate the
efficacy of physiotherapy (8 individual sessions over 12 weeks, as well as a home exercise program
4 times/week) compared to a physiotherapist-delivered OA education control treatment (8
individual sessions over 12 weeks). Physiotherapy treatment will consist of (i) quadriceps muscle
retraining; (ii) quadriceps and hip muscle strengthening; (iii) patellar taping; (iv) manual PFJ and soft
tissue mobilisation; and (v) OA education. Resistance and dosage of exercises will be tailored to
the participant's functional level and clinical state. Primary outcomes will be evaluated by a blinded
examiner at baseline, 12 weeks and 9 months using validated and reliable pain, physical function and
perceived global effect scales. All analyses will be conducted on an intention-to-treat basis using
linear mixed regression models, including respective baseline scores as a covariate, subjects as a
random effect, treatment condition as a fixed factor and the covariate by treatment interaction.
Conclusion: This RCT is targeting PFJ OA, an important sub-group of knee OA patients, with a
specifically designed conservative intervention. The project's outcome will influence PFJ OA
rehabilitation, with the potential to reduce the personal and societal burden of this increasing public
health problem.
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Background
Osteoarthritis (OA) is the leading cause of musculoskele-
tal pain and disability and is the third leading cause of life-
years lost due to disability in Australia, only behind
depression and dementia [1]. The annual total cost of
arthritic disease in Australia is estimated at $24 billion [2],
with the knee joint contributing substantially to this over-
all cost. The prevalence of OA in people aged over 55 years
is 20–26% and rising, with arthritis rates expected to
increase by 30% over the next 40 years [2]. The pain and
suffering endured by patients as a result of OA decreases
their quality of life, with the annual burden of disease
costs ($12 billion in Australia) being half the total costs
associated with this condition [2]. Pain associated with
daily activities such as walking and stair-climbing ulti-
mately leads to profoundly reduced functional independ-
ence [2].
The patellofemoral joint (PFJ) is one of the three knee
joint compartments. Awareness of its importance in the
OA process has been raised by the increasing use of lateral
and skyline x-rays in recent times. Research has revealed
that PFJ OA is more common than previously thought. In
a community-based study of knee OA (N = 218), the fre-
quency of radiographic osteophytes was greater in the PFJ
(65% knees) than in the tibiofemoral joint (TFJ) (55%
knees) [3]. Furthermore, in people with knee pain (N =
777), the most common compartmental distribution of
radiographic OA was a combination of TFJ and PFJ disease
(40%), followed by isolated PFJ OA (24%), and isolated
TFJ disease (4%) [4]. Within the PFJ, the lateral compart-
ment is more frequently affected by the OA process than
the medial [5,6]. Importantly, the presence of baseline PFJ
OA predicts structural deterioration in the TFJ compart-
ment over 30 months (OR 2.31, 95% CI 1.37, 3.88) [7].
The PFJ is an important source of symptoms associated
with knee OA [8]. Knee pain has been found to be signif-
icantly associated with PFJ osteophytes (OR 2.25, 95%CI
1.06, 4.77), but not TFJ osteophytes (OR 1.19, 95% CI
0.46, 3.09) [9], suggesting that the PFJ may be a more
important source of knee pain than the TFJ. Hunter et al
[10] noted that increased pain and poorer function was
associated with reduced cartilage volume in the patella,
but not in the femur nor the tibia. Other authors have
confirmed the relationship between radiographic PFJ OA
and knee pain [11-13].
Management strategies for knee OA have traditionally
focussed on alleviating symptoms, primarily using drug
therapies or surgery. A meta-analysis of OA trials high-
lights this, with most trials evaluating drug treatments
(60%) or surgical procedures (26%) [14]. OA experts have
highlighted the overall dearth of quality evidence to sup-
port the use of non-pharmacological interventions such as
physiotherapy. Despite this, knee OA clinical guidelines
recommend that conservative treatments be included as a
first line strategy for the optimal management of the dis-
ease [15,16]. Physiotherapy is a conservative intervention,
which is non-toxic, inexpensive and promotes physical
activity and self management through exercise. Therefore,
rigorous randomised clinical trials (RCTs) that evaluate
the efficacy of physiotherapy are clearly needed, to better
guide clinical decision-making.
Given the heterogeneity of knee OA with regard to aetiol-
ogy, clinical presentation and natural history, guidelines
also recommend the tailoring of knee OA treatments to
the location of joint damage in order to optimise treat-
ment outcomes [15,16]. However, most trials of physio-
therapy for knee OA have not been targeted to disease
subgroups, with participant selection typically based on
the presence of non-specific knee pain and radiographic
changes anywhere on an anteroposterior radiograph.
While a plethora of evidence attests to the benefits of exer-
cise for patients with predominant TFJ OA [17] there is no
level I evidence and only one RCT [18] specifically
addressing the problem of PFJ OA. The dearth of evidence
for a compartment-specific treatment for PFJ OA necessi-
tates our proposed study to establish the efficacy of a com-
partment-specific physiotherapy treatment using the
rigour of a RCT.
While there is little known about the physical impair-
ments associated with PFJ OA, there are several RCTs that
have evaluated physical interventions for PFJ pain in
younger adults (patellofemoral pain syndrome, or ante-
rior knee pain). We have previously conducted a double
blind, placebo-controlled RCT [19], which demonstrated
the efficacy of a targeted physiotherapy program for this
patient population. The targeted treatment involved (i)
quadriceps muscle retraining; (ii) patellar taping; (iii)
manual PFJ and soft tissue mobilisation; and (iv) hip
muscle retraining. We have recently confirmed the benefi-
cial effects of this targeted physiotherapy approach on
pain and physical function in another population of
young adults with PFJ pain [20]. Therefore, we are propos-
ing to evaluate a similar, targeted physiotherapy interven-
tion for people with PFJ OA.
This project aims to evaluate whether a physiotherapy
treatment, targeted to the PFJ and based on successful
treatment for PFJ pain in younger populations, results in
greater improvements in pain and physical function than
a physiotherapy education intervention in participants
with symptomatic and radiographic PFJ OA.
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Methods
Experimental design
A randomised, single-blind, controlled clinical trial con-
forming to CONSORT [21] guidelines will be conducted,
comparing a multimodal physiotherapy intervention to a
physiotherapy education intervention (Figure 1). A
Project Investigator will screen for eligibility based on his-
tory, clinical and radiographic examination.
Ethical approval has been obtained from the University of
Melbourne Human Research Ethics Committee (HREC
No. 0721163) and from the Department of Human Serv-
ices Victoria, Radiation Safety Committee. All participants
will provide written informed consent.
Participants
Ninety people with lateral PFJ OA will be recruited from
the community via advertisements, medical practitioners
and our own research database. To be included in the
study, participants must fulfil the following criteria: (i)
aged > 40 years; (ii) anterior- or retro-patellar knee pain
aggravated by at least two activities that load the PFJ (eg
stair ambulation, squatting and/or rising from sitting);
(iii) pain severity ≥ 4 on an 11 point numerical pain scale
during aggravating activities; (iv) pain during these activi-
ties present on most days during the past month; (v) oste-
ophyte grade ≥ 1 in the lateral PFJ compartment on
skyline x-ray [22].
Exclusion criteria will include: (i) concomitant pain from
other knee structures, hip or lumbar spine; (ii) current or
previous physiotherapy for knee pain (prior 12 months);
(iii) contra-indications to the treatments (eg tape allergy);
(iv) recent knee injections (prior 3 months); (v) planned
lower limb surgery in the following 9 months; (vi) body
mass index ≥ 35 kg.m2; (vii) medial PFJ OA (osteophytes
Flow of participants through the randomised controlled trialigure 1
Flow of participants through the randomised controlled trial.
Telephone screening
Consent; X-ray and 
physical exam
screening
Baseline: baseline assessment (blinded assessor) and randomisation (N = 90)
Multi-modal 
physiotherapy
Ineligible
Fail inclusion criteria
Meet exclusion criteria
Ineligible
Fail inclusion criteria
Meet exclusion criteria
Physiotherapy 
education control
12 weeks: follow-up assessment (blinded assessor)
9 months: follow-up assessment (blinded assessor)
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
BMC Musculoskeletal Disorders 2008, 9:122 http://www.biomedcentral.com/1471-2474/9/122
Page 4 of 9
(page number not for citation purposes)
or joint space narrowing on a skyline x-ray) that is more
severe than lateral PFJ OA; (viii) moderate to severe con-
comitant TFJ OA (Kellgren and Lawrence grade ≥ 3 on an
anteroposterior radiograph) [23]; (ix) knee or hip arthro-
plasty or osteotomy; (xi) physical inability to undertake
testing procedures or; (x) inability to understand written
and spoken English.
Sample Size
Treatment efficacy will be evaluated by comparing change
on primary outcome measures between groups. We aim to
detect the minimum clinically important improvement
on these outcomes as reported by Tubach et al [24]. Spe-
cifically, a sample of 90 will provide a minimum of 90%
power (α = 0.05) to detect a difference in pain on visual
analogue scale (VAS) of 19.9 (21.5) mm and a difference
in physical function on the Western Ontario MacMaster
Universities Osteoarthritis Index (WOMAC) [25] of 9.1
(13.9) normalised units. This sample size also allows for
an estimated 10% drop-out rate.
Procedure
The randomisation schedule (permuted blocks of 8 to 12)
will be generated and maintained centrally by one of the
investigators (BV), who will not be involved in assessment
of participants. The randomisation schedule will be
revealed via telephone following baseline assessment. A
blinded investigator will perform outcome assessments
(Table 1) at baseline, 12 weeks and 9 months, and partic-
ipants will be instructed not to divulge their group alloca-
tion. Security of the blinding system will be evaluated to
ensure integrity.
Outcome assessment
Age, gender, duration of knee OA symptoms, previous
treatment, surgery and medication use for knee OA will be
obtained at the baseline assessment.
Primary outcome measures: Pain and physical function
Overall average knee pain in the previous week on move-
ment and during an aggravating activity nominated by the
participant will be self-assessed with a 0–100 mm hori-
zontal visual analogue scale (VAS) with terminal descrip-
tors of (0 = no pain; 10 = maximal pain). Self-reported
Table 1: Outcome measures used in the randomised controlled trial
Primary Outcome Measurement
Usual pain on movement in the previous week 0–100 mm visual analogue scale (VAS) with terminal descriptors: 0 = no 
pain; 10 = maximal pain
Usual pain during nominated aggravating activity in the previous week 0–100 mm visual analogue scale (VAS) with terminal descriptors: 0 = no 
pain; 10 = maximal pain
Self reported difficulty with physical function Physical Function subscale of the Western and Onatario MacMasters 
University (WOMAC) Osteoarthritis Index (Likert version)
Secondary Outcomes Measurement
Symptoms
Pain and stiffness Pain and Stiffness subscales of the WOMAC
Perceived global effect score 5 point ordinal scale 
(1-much improved; 2-improved. 3-same; 4-worse; 5-much worse)
Sports and recreation function Sports and recreation function dimension of the Knee Injury and 
Osteoarthritis Score (KOOS)
Symptoms Symptoms dimension of the KOOS
Knee related quality-of-life Knee related quality-of-life dimension of the KOOS
Function
Lower extremity functional performance One-leg rise test – maximum number of one-leg rises from sitting on a 0.48 
m stool
Stair ambulation performance Timed stair ascent and descent
Standing balance Step test – number of times can step foot up and down off 15 cm step in 15 
s
Other Outcomes Measurement
Physical activity levels Physical Activity Scale for the Elderly (PASE)
Adherence (physiotherapy group only) Number of physiotherapy visits Completion of home exercises via log-
book
Knee-related medication use Log-book
Adverse effects Log-book and open probe questioning
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difficulty with physical function will be assessed using the
physical function subscale of the Likert version of the
WOMAC [25]. This disease-specific measure is reliable,
valid and responsive and comprises 17 items, using a 5-
point scale to score each, where higher scores indicate
worse symptoms.
Secondary outcome measures
Pain and stiffness will be assessed using the relevant sub-
scales of the WOMAC [25]. Participants will rate their per-
ceived overall change in symptoms following treatment
on a 5 point ordinal scale: 1-much improved, 2-improved,
3-no change, 4-worse, 5-much worse, giving a perceived
global effect score. Sports and recreation function, symptoms
and knee-related quality-of-life will be assessed using the rel-
evant dimensions of the Knee Injury and Osteoarthritis
Outcome Score (KOOS) [26].
Objective measures of function will include the one-leg rise
test, a timed stair ambulation test and the step-test. The
one-leg rise test is the maximum number of one-leg rises
the participant can perform from sitting on a stool. The
participant must hold their non-test leg out straight and
cannot use their arms for assistance. The number of rises
that the participant can complete will be recorded. This
test is a measure of lower extremity functional perform-
ance that has been found to predict the development of
radiographic knee OA in middle aged people with chronic
knee pain [27]. The timed stair ambulation task involves
the participant ascending and descending a set of nine
standard steps at their usual pace and the total time taken
recorded, with longer time taken indicating poorer physi-
cal function [28]. The step-test is a functional, dynamic
test of standing balance, where the participants stands on
one leg in front of a 15 cm step, and places the opposite
foot on and off the step as quickly as possible over 15 sec-
onds. The total number of successful steps are recorded,
with higher scores indicating better balance [29].
Other measures
Disease severity of the TFJ from weight bearing anteropos-
terior knee x-rays taken at screening will be determined
using the Kellgren and Lawrence grading system [23]
where 0 = normal; 1 = possible osteophytes; 2 = minimal
osteophytes and possible joint space narrowing; 3 = mod-
erate osteophytes, some narrowing and possible sclerosis
and; 4 = large osteophytes, definite narrowing and severe
sclerosis. PFJ OA will be assessed from a skyline x-ray
using a radiographic atlas [22]. The medial and lateral PFJ
compartments will each be scored separately for the pres-
ence of osteophytes and joint space narrowing where 0 =
normal; 1 = mild or 1–33% abnormal; 2 = moderate or
34–66% abnormal and; 3 = severe or 67–100% abnormal.
Co-interventions, adherence and adverse effects will also be
recorded. Participants will be asked to refrain from other
forms of OA treatment, but stable drug doses will be per-
mitted. Physiotherapists will record attendance, details of
treatment progression (physiotherapy group) and adverse
events. Participants will record adherence with home exer-
cises (physiotherapy group), adverse events and any co-
interventions, including knee-related medication use in a
log-book.
Interventions
Each participant will be treated by an experienced and reg-
istered physiotherapist. Treating practitioners will be
trained and proficient in both of the interventions (phys-
iotherapy and education control). Each treatment will be
delivered in 8 sessions over 12 weeks (once per week for
four weeks, then once every two weeks for 8 weeks). Rea-
sonable costs associated with treatments will be met by
the project.
Physiotherapy Treatment
The physiotherapy treatment will be similar to that
employed in our previous RCTs for patellofemoral pain in
younger people [19,20]. Treatment will consist of (i) func-
tional retraining exercises for the quadriceps muscle; (ii)
quadriceps and hip muscle strengthening; (iii) patellar
taping; (iv) manual PFJ and soft tissue mobilisation; and
(v) OA education. The treatment will be tailored accord-
ing to each participant's clinical presentation (eg strength,
pain severity, swelling) as well as the presence of co-mor-
bidities (eg back and hip pain or pathology), and will be
progressed based on individual response to exercise load,
thus optimising treatment effects. Exercises will be taught
and supervised by the physiotherapist during each visit. A
home exercise program will be prescribed, to be per-
formed independently at home 4 times per week. An exer-
cise manual for participants will be produced, with clear
instructions and diagrams to ensure correct and safe per-
formance of exercise. Specific aspects of the treatment are
outlined in Table 2 and will include:
(i) Functional retraining exercises for the quadriceps mus-
cle. The muscle retraining is designed to enhance the co-
ordination (magnitude and onset timing) of the medial
quadriceps, relative to the lateral utilising biofeedback
within the sessions. In order to accommodate a patient
group with heterogeneous symptoms, the functional
retraining exercises may be performed statically and/or
dynamically during various functional activities (eg step
up, step down, sit to stand).
(ii) Quadriceps and hip abduction strengthening. The
exercise selection will be based on baseline capacity of the
individual and then progressed, based on response to
exercise load, thus maximising the training effects. Resist-
ance will be provided by weights, rubber tubing and/or
body weight.
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(iii) Patellar taping to reduce pain using the same stand-
ardised protocol as per our previous knee OA research
[30,31]. The tape will be applied by the physiotherapist at
each visit, worn continuously for one week and then
removed.
(iv) Manual PFJ and soft tissue mobilisation, comprising
medial patellar glides and massage to the lateral soft tissue
structures, performed by the physiotherapist.
(v) OA education covering topics such as exercise, diet,
weight loss etc.
Following cessation of supervised physiotherapy sessions
at 12 weeks, participants will be instructed to continue
with a home exercise program. Adherence to the program
will be monitored from the diary recordings of exercise
completions.
Physiotherapy Education Control
In order to control for the psychosocial contact inherent
with the physiotherapy treatment, participants allocated
to the control group will attend individualised OA educa-
tion sessions covering topics such as exercise, diet, weight
loss, etc, provided by the physiotherapist with the same
frequency as the physiotherapy sessions.
Data quality and management
Strategies employed to ensure data quality include: (i)
training of assessors and physiotherapists; (ii) assessment
of procedural quality; (iii) random checks by investigators
of adherence to study protocols; and (iv) random checks
of forms for completeness and data for accuracy. All anal-
yses will be conducted on an intention-to-treat basis. The
primary outcomes measured at 12 weeks and 9 months
will be analysed using linear mixed regression models,
including their respective baseline scores as a covariate,
subjects as a random effect, treatment condition as a fixed
factor and the covariate by treatment interaction. Partici-
pant characteristics (eg; gender, radiographic severity of
TFJ and PFJ OA) will also be included as covariates.
Regression diagnostics will be used to check for normality
of the measures and homogeneity of variance, where
appropriate. Comparisons between group means will be
performed using Bonferroni or Newman Keuls range tests.
An alpha level of 0.05 will be used. Calculation of the
number needed to treat index will be performed to facili-
tate the development of clinical guidelines.
Discussion and Conclusion
PFJ OA is emerging as a distinct clinical entity that is com-
mon, is associated with considerable pain and disability,
and is an important and novel area of research, since little
is known about the optimal management of this condi-
tion. This study uses a single-blind RCT design to investi-
gate whether a multimodal physiotherapy treatment,
targeted to the PFJ, is more effective in reducing pain and
improving physical function than a physiotherapy educa-
tion control intervention in people with PFJ OA. As a sec-
ondary aim, it will evaluate whether the targeted
physiotherapy treatment results in greater perceived
improvement, self-reported stiffness, pain, sport and rec-
reational function, symptoms and knee-related quality of
life, as well as performance on functionally relevant tasks
(one-leg rises, timed stair ambulation, and step-test) than
the physiotherapy education control intervention.
Table 2: Physiotherapy treatment components
Functional retraining exercises† performed four times/week – participants perform a contraction of medial quadriceps in 
two of the following functional activities
- sitting (isometric)
- sit-stand
- step up
- single leg squat
Quadriceps muscle strengthening† performed four times/week – participants complete one exercise in each of the following
- inner range (open kinetic chain)
- mid range (open kinetic chain)
- weight-bearing (wall squat)
Hip abduction strengthening† performed four times/week
- sidelying hip abduction
Patellar taping
- combination of tilt, medial glide and fat pad unloading – tape will be applied by the physiotherapist at each visit, worn continuously for one 
week and then removed
-
Patellofemoral and soft-tissue mobilisation
- mobilisation of the patella (medial glides) performed by the physiotherapists
- massage to the painful and tight soft tissue structures, performed by the physiotherapist
†Exact exercise and its number of repetitions will be determined by the physiotherapist from a schedule of permissible exercises based on each 
participant's clinical presentation (eg strength, pain severity, swelling), presence of comorbidities (eg back and hip pain or pathology) and will be 
progressed based on individual response to exercise load
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In contrast to OA primarily affecting the TFJ, compara-
tively little known about the features or impairments asso-
ciated with OA of the PFJ, and hence designing a targeted
intervention is challenging. Thus, we have chosen to
investigate a physiotherapy intervention that is largely
based on a program that we have previously found to be
successful in younger people with PFJ pain (patellofemo-
ral pain syndrome) [19,20]. Components of this targeted
intervention include: (i) functional retraining of the quad-
riceps muscle; (ii) quadriceps and hip muscle strengthen-
ing; (iii) patellar taping; (iv) manual PFJ and soft tissue
mobilisation; and (v) OA education. This intervention is
currently considered to be "best-practice" in the manage-
ment of PFJ pain, and is increasingly being employed clin-
ically in the management of people with PFJ OA.
An impairment that has been the subject of recent evalua-
tion in participants with generalised knee OA is patellar
malalignment. Patellar malalignment is typically exhib-
ited as lateral patellar tilt, displacement or subluxation
and may be important in PFJ OA by reducing and lateral-
ising the PFJ contact area [32], thus increasing stress in
this compartment. In people with knee OA, PFJ malalign-
ment has been shown to be associated with indices of OA
(joint space narrowing and loss of cartilage thickness)
[33,34] as well as progression of OA (joint space narrow-
ing) [35] in the PFJ compartment and increased func-
tional impairment [36]. Thus, PFJ malalignment is a key
feature of PFJ OA that could be amenable to a targeted
intervention such as physiotherapy. This supports the
inclusion of patellar tape in our targeted treatment, since
it has the potential to reduce patellar malalignment [37-
39] and we have already shown that patellar tape can
reduce knee pain in generalised knee OA populations
[30,31]. Other treatment modalities (eg PFJ and soft tissue
mobilisations), may assist in the treatment of PFJ pain
and malalignment in this patient population.
The balance of medial and lateral quadriceps activity is
essential to maintain PFJ alignment. Experimental studies
confirm that reduced or delayed medial quadriceps activ-
ity (relative to the lateral quadriceps) increases lateral
patellar malalignment, leading to areas of heightened
contact stress across the lateral PFJ compartment [40,41].
Thus, the balance of muscle activation between the
medial and lateral quadriceps may be important in PFJ
disease. In our studies of younger people with PFJ pain
[42,43], we have observed a temporal delay in medial
quadriceps activity. Thus, it is likely that individuals with
PFJ OA may require a specific retraining program designed
to restore balanced quadriceps activity.
While the role of hip muscle function in PFJ OA has not
been investigated, there is increasing evidence that hip
muscle function is impaired (reduced strength [44],
delayed hip muscle activity [45]; and altered hip move-
ments during ambulation [46]) in other PFJ conditions.
These studies indicate that hip abduction is particularly
relevant in patients with PFJ pain and hence, this study is
focusing on strengthening hip abduction. Furthermore,
the inclusion of a hip abduction strengthening program in
this study reflects contemporary clinical practice.
While the main goal of treatment for OA is to reduce pain
and disability, it is not known how non-pharmacological
interventions achieve this goal; such is the complex multi-
factorial nature of OA pain. Our intervention is based on
reversing the compartment-specific impairments likely to
be associated with PFJ OA. Furthermore, this intervention
builds on our previous studies, which have established
that: (i) taping the patella medially reduces pain and dis-
ability associated with non-specific knee OA [30,31,47]
and may reduce PFJ malalignment [48] and (ii) a quadri-
ceps retraining program can reduce pain and disability, as
well as restore quadriceps muscle activation patterns in
younger people with PFJ pain [19,49,50]. Our unique
RCT is targeting PFJ OA, an important sub-group of knee
OA, with a specifically designed intervention. The
project's outcome will influence knee OA rehabilitation,
thus reducing the personal and societal burden of this
increasing public health problem.
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Supplementary Table. PFJ-targeted physiotherapy treatment elements 
Components Explanation Rationale and/or Dosage 
Functional 
retraining 
exercises
 
for 
the quadriceps 
and hip 
muscles
†
  
 
Retraining of the vasti (aiming for similar or 
greater activation in the medial, relative to the 
lateral vasti) and hip abductor/external rotator 
activity was performed in one exercise from each 
of the following: 
Functional retraining A 
- Sitting (isometric) or 
- Sit to stand 
Functional retraining B 
- Stepping up or 
- Single leg squat 
Biofeedback to facilitate vastus medialis 
activation was only used in physiotherapy 
sessions. 
Patellar malalignment from altered vasti function 
[46]
 or excessive 
femoral rotation 
[47, 48]
 can lead to altered patellofemoral stress. 
Retraining aims to address these impairments. 
The commencing level and progressions were determined as the 
highest level that the participant could complete with pain <2 (0-10 
numerical rating scale (NRS)) and whilst exhibiting optimal postural 
control (determined by therapist).  
Dosage was progressed (e.g. from 1 set of 10 repetitions through to 
3 sets of 10 repetitions) and resistance provided through increasing 
hold times (e.g. from 0 to 10 seconds) for the sit-stand exercise and 
with increasing knee flexion and handheld weights for the single leg 
squats. All exercises were checked and progressed during the 
physiotherapy visits, and were conducted unsupervised at home 4 
times per week, adherence and pain checked at each physiotherapy 
visit. 
Quadriceps 
muscle 
strengthening
†
  
 
Participants completed one exercise in each of 
the following activities: 
(i)- inner range (open kinetic chain) 
(ii)- mid range (open kinetic chain) 
(iii)- weight-bearing (wall squat) 
Greater quadriceps muscle strength can protect against patellar 
cartilage loss. 
[41]
. Quadriceps atrophy is a feature of PFJ OA 
[26]
 and 
was addressed with a strengthening program. 
 Commencing level and progressions were determined as the 
highest level that the participant could complete with pain <2 (0-10 
NRS) and exertion at least 5 (0-10 NRS). 
Dosage was progressed through the phases (e.g. from 1 set of 5 
repetitions through to 3 sets of 15 repetitions) and resistance 
provided through increasing hold times, weights or resistance 
tubing (different grades). All exercises were checked and progressed 
during the physiotherapy visits, and were conducted unsupervised 
at home 4 times per week, adherence, pain and exertion checked at 
each physiotherapy visit. 
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Hip abduction 
strengthening
†
  
Side lying hip abduction exercises.  Hip abduction dysfunction is a feature of PFJ OA 
[24, 28]
, and was 
addressed with a strengthening program. 
Exercises were progressed in 12 phases, commencing at the highest 
level that the participant could complete with pain <2 (0-10 NRS) 
and exertion at least 5 (0-10 NRS). 
 Dosage was progressed from 3 to 4 set of 10 repetitions) and 
resistance provided through increasing hold times or weights). All 
exercises were checked and progressed during the physiotherapy 
visits, and were conducted unsupervised at home 4 times per week, 
adherence, pain and exertion checked at each physiotherapy visit. 
Patellar taping 
 
The taping techniques were applied in a pre-
determined order (combination of tilt, medial 
glide and fat pad unloading), until the 
participant’s pain was reduced by 50%.  
Patellar malalignment is a feature of PFJ OA that can be addressed 
with taping 
[23]
. 
The regular rigid strapping tape was applied by the physiotherapist 
at each visit, worn continuously for one week and then removed. 
Patellofemoral, 
tibiofemoral 
and soft-tissue 
mobilisation 
Manual patellar (e.g. medial glides) and 
tibiofemoral mobilisations (antero-posterior 
glides) 
Massage to the painful and tight soft tissue 
structures (e.g. lateral retinacular/iliotibial band) 
Mobilisations have potential to improve joint pain 
[49]
. Since walking 
on a flexed knee can increase the patellofemoral joint load, 
mobilisations were used to restore knee extension when restricted 
[50]
. 
Techniques were provided when deemed appropriate by the 
physiotherapist based on assessment findings (e.g. to provide pain 
relief to assist pain-free exercises or activities of daily living). 
Provided only during physiotherapy sessions 
OA education Information sheets from the Arthritis Victoria 
website (http://www.arthritisvic.org.au) provided 
in eight sessions: 
1a. What is arthritis? 
1b. Osteoarthritis 
1c. Tips for osteoarthritis of the hip or knee 
2.   Healthy eating and arthritis 
3.   Physical activity 
Education sheets provided and patient-identified issues discussed 
with physiotherapist. 
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4.   Dealing with pain 
5.   Medicines and arthritis 
6a. Complementary therapies 
6b. Glucosamine and chondroitin 
6c. Fish oils 
7a. Arthritis and emotions 
7b. Saving energy 
8.   Taking control of your Osteoarthritis (booklet) 
†
Exact exercise and its number of repetitions were determined by the physiotherapist from a schedule of permissible exercises based on each 
participant’s clinical presentation (e.g. strength, pain severity, swelling), presence of comorbidities (e.g. back and hip pain or pathology) and 
were progressed based on individual response to exercise load. While each person was started and progressed at an individual level (based on 
their strength/control or pain), the phases (see dosage) were standardised. 
 
